Strides Global Consumer Healthcare Limited – Trademark Portfolio
Entity Type: 78
Strides Global Consumer Healthcare Limited holds 12 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 10 filings in this category. The portfolio also extends into Class 10 (Medical Apparatus) across 2 Nice Classification classes. Currently, 3 trademarks are registered and 1 is pending. Notable registered marks include NUPRIN, NITE THRU, and DREAMSCENT. The owner is based in Watford, Hertfordshire.
Unit 4, Metro Centre, Tolpits Lane
Watford, Hertfordshire WD189SS , GB
Showing of trademarks Trademarks
Trademark Classifications
Strides Global Consumer Healthcare Limited's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Frequently Asked Questions
How many trademarks does Strides Global Consumer Healthcare Limited have?
Strides Global Consumer Healthcare Limited has 12 U.S. trademarks filed with the USPTO. Of these, 3 registered, 1 pending, 5 abandoned, 3 cancelled.
What trademark classes does Strides Global Consumer Healthcare Limited file in?
Strides Global Consumer Healthcare Limited files trademarks across 2 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are Strides Global Consumer Healthcare Limited's most well-known trademarks?
Strides Global Consumer Healthcare Limited's registered trademark portfolio includes well-known marks such as NUPRIN, NITE THRU, and DREAMSCENT. These are among 3 currently registered trademarks in the portfolio.
What is Strides Global Consumer Healthcare Limited's trademark registration success rate?
Strides Global Consumer Healthcare Limited has a 27% trademark registration rate, with 3 out of 11 resolved applications resulting in successful registration. Currently, 1 application is pending review.